Array Biopharma Announces Library Agreement with Immunex
Boulder, Colo. – (October 3, 2000) - Array BioPharma Inc. today announced that it has signed a multi-year agreement to provide Immunex Corporation with access to small molecule libraries for screening against Immunex’s high throughput screening assays. Under the terms of this agreement, Immunex will gain access to Array’s libraries on a non-exclusive basis. Array retains an exclusive option to enter into a lead optimization agreement with Immunex to develop leads generated from Immunex’s screening of Array’s library. Financial terms were not disclosed.
Array BioPharma, Inc., is a discovery research company creating drug candidates through innovations in chemistry. Array scientists provide products and services to create, evaluate and optimize potential drug candidates in collaboration with pharmaceutical and biotechnology companies. For additional information, visit the company’s web site at www.arraybiopharma.com.